Patents by Inventor Brant C. Hendrickson

Brant C. Hendrickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080318223
    Abstract: Large deletions have been identified in the BRCA1 gene in patients. The large deletions predispose the patients to breast cancer and ovarian cancer. Thus, methods for detecting the genetic variants are provided which can be used in detecting a predisposition to cancer.
    Type: Application
    Filed: July 30, 2007
    Publication date: December 25, 2008
    Applicant: Myriad Genetics, Incorporated
    Inventors: Thomas Scholl, Brant C. Hendrickson, Benjamin Ward, Dmitry Pruss
  • Publication number: 20080318224
    Abstract: Large deletions have been identified in the BRCA1 gene in patients. The large deletions predispose the patients to breast cancer and ovarian cancer. Thus, methods for detecting the genetic variants are provided which can be used in detecting a predisposition to cancer.
    Type: Application
    Filed: July 30, 2007
    Publication date: December 25, 2008
    Applicant: Myriad Genetics, Incorporated
    Inventors: Thomas Scholl, Brant C. Hendrickson, Benjamin Ward, Dmitry Pruss
  • Patent number: 7250497
    Abstract: Large deletions have been identified in the BRCA1 gene in patients. The large deletions predispose the patients to breast cancer and ovarian cancer. Thus, methods for detecting the genetic variants are provided which can be used in detecting a predisposition to cancer.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: July 31, 2007
    Assignee: Myriad Genetics, Inc.
    Inventors: Thomas Scholl, Brant C. Hendrickson, Benjamin Ward, Dmitry Pruss
  • Patent number: 6895337
    Abstract: Methods, computer program products and systems are provided for detecting large genomic rearrangements based on unphased genotype data obtained using common genotyping techniques that do not differentiate different alleles. In the method, unphased genotypes at a plurality of nucleotide variant markers of a particular gene in a diploid subject are compared with a canonical haplotype collection of the gene for a heterogeneous subject population. If the unphased genotypes cannot be reduced to a pair of canonical haplotypes within the canonical haplotype collection, it would indicate an increased likelihood that an allele of the gene in the diploid subject harbors a genomic rearrangement.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: May 17, 2005
    Assignee: Myriad Genetics, Inc.
    Inventors: Thomas Scholl, Dmitry Pruss, Brant C. Hendrickson
  • Publication number: 20040014115
    Abstract: Large deletions have been identified in the BRCA1 gene in patients. The large deletions predispose the patients to breast cancer and ovarian cancer. Thus, methods for detecting the genetic variants are provided which can be used in detecting a predisposition to cancer.
    Type: Application
    Filed: June 9, 2003
    Publication date: January 22, 2004
    Applicant: Myriad Genetics, Incorporated
    Inventors: Thomas Scholl, Brant C. Hendrickson, Benjamin Ward, Dmitry Pruss